Lv2
152 积分 2021-01-05 加入
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
6个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
9个月前
已完结
VE-822, a novel DNA Holliday junction stabilizer, inhibits homologous recombination repair and triggers DNA damage response in osteogenic sarcomas
11个月前
已完结
Structure–Activity Relationships of Bis-Intercalating Peptides and Their Application as Antibody–Drug Conjugate Payloads
1年前
已完结
Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer Immunotherapy
1年前
已完结
皖公网安备34019202002308
